Davenport & CO LLC Organon & Co. Transaction History

Davenport & CO LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$13.78 - $18.8 $5,181 - $7,068	376 Added 3.57%	10,918 $205,000
Q4 2023 Jan 23, 2024	SELL	$10.95 - $17.32 $55,658 - $88,037	-5,083 Reduced 32.53%	10,542 $152,000
Q3 2023 Oct 17, 2023	SELL	$16.59 - $23.77 $25,797 - $36,962	-1,555 Reduced 9.05%	15,625 $271,000
Q2 2023 Jul 20, 2023	SELL	$19.27 - $24.63 $83,304 - $106,475	-4,323 Reduced 20.1%	17,180 $357,000
Q1 2023 Apr 27, 2023	SELL	$21.42 - $32.08 $65,952 - $98,774	-3,079 Reduced 12.53%	21,503 $505,000
Q4 2022 Jan 20, 2023	BUY	$23.31 - $28.61 $6,177 - $7,581	265 Added 1.09%	24,582 $0
Q3 2022 Oct 11, 2022	BUY	$23.4 - $34.25 $26,746 - $39,147	1,143 Added 4.93%	24,317 $569,000
Q2 2022 Jul 18, 2022	SELL	$31.66 - $38.9 $42,772 - $52,553	-1,351 Reduced 5.51%	23,174 $782,000
Q1 2022 May 02, 2022	BUY	$30.45 - $39.36 $57,002 - $73,681	1,872 Added 8.26%	24,525 $857,000
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $179,015 - $231,839	-6,244 Reduced 21.61%	22,653 $690,000
Q3 2021 Oct 14, 2021	BUY	$28.63 - $35.64 $112,229 - $139,708	3,920 Added 15.69%	28,897 $948,000
Q2 2021 Jul 28, 2021	BUY	$28.45 - $38.0 $710,595 - $949,126	24,977 New	24,977 $756,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.